Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DESiN is a private U.S. medical device company focused on assistive feeding technology for people who cannot eat independently because of upper-extremity functional limitations. Its flagship and apparently sole commercial product is Obi, a robotic self-feeding device intended to compensate for the function of a human arm during meals and restore self-feeding performance. The company designs, manufactures, services, and distributes Obi and related accessories from its facility in Jacksonville, Florida, and markets the device for adults and children with physical disabilities or impairments. DESiN appears to operate as a family-founded, small commercial-stage company rather than a therapeutics developer, with regulatory and quality documentation indicating active medical-device operations and ISO 13485-certified processes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DESiN.